VANCOUVER, British Columbia, Oct. 17, 2017 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (the “Company” or
“RavenQuest”) - (CSE:RQB) is pleased to announce the appointment of five core members of its operational team. The
following key individuals will report directly to CEO, George Robinson:
Bill Robinson (no relation) will lead the Company’s efforts in Government/Indigenous
Relations and Strategic Partnerships. In this newly created and important role, Mr. Robinson's mandate will be to
identify, cultivate and deepen trusting relationships with Federal and Provincial government bodies – Indigenous Peoples or
otherwise - as well as to foster mutually beneficial partnerships with select Indigenous Peoples across Canada, specific to the
legal production and sale of cannabis.
Benilda Sable will oversee the Company’s unparalleled Quality Assurance and
Compliance standards. Benil brings to the Company her expertise from the food, hemp and medical marijuana industries
especially with Health Canada, the Government of Canada’s primary front-line inspection agency in Canada’s cannabis sector.
Ms. Sable’s experience will be invaluable in ensuring the Company consistently maintains and surpasses the rigorous quality and
compliance guidelines set out by Health Canada.
Noel Avila will act as the Company’s direct conduit to newly acquired Alberta Green
Biotech. Noel oversees all aspects of the construction, licensing and completion of the 35,500 square foot
production facility in Edmonton, Alberta, slated for completion in mid-2018.
Jason Morris is responsible for the Company's Service Delivery and overall
Project Management. Jason oversees delivery of security technology, automated
horticultural systems and patient management software to the Company’s diverse list of clients. Much of the
Company’s research and business development activities fall under Jason's responsibility.
David Cross, CPA, CGA brings 20 years of public practise as a CPA to the Company and will act
as the Company’s Chief Financial Officer.
Marla Ritchie brings 25 years’ experience in public markets and will act as the Company’s
Corporate Secretary, overseeing all aspects of the Company’s administrative, filing and regulatory requirements
pertaining to public company status and trading on the CSE.
“Our organization is fortunate in our ability to field a team of individuals with such an impressive depth of
knowledge and experience in each of their respective areas of expertise,” stated George Robinson, RavenQuest’s CEO.
About RavenQuest Biomed Inc.
RavenQuest Biomed Inc. is a diversified publicly traded cannabis company with divisions focused upon cannabis
production, management services & consulting and specialized research & development.
For further details on the Company readers are referred to the Company's web site (www.rqbglobal.com) and its Canadian regulatory filings on SEDAR at www.sedar.com.
On Behalf of the Board of Directors of
RAVENQUEST BIOMED INC.
"George Robinson"
Chief Executive Officer
For further information, please contact:
Mathieu McDonald, Corporate Communications
1-877-282-1586
Neither Canadian Stock Exchange (“CSE”) nor its Regulation Services Provider (as that term is defined in the
policies of the Canadian Stock Exchange) accepts responsibility for the adequacy or accuracy of this press release, which has been
prepared by management.
